Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 2, 1999, Pages 105-114

  Kitamura, Yoshihiro ^a,d   Ishikawa, Tetsuya ^a   Okui, Nobuo ^a,b   Kobayashi, Noriko ^a   Kanda, Tadahito ^a   Shimada, Takashi ^c   Miyake, Koichi ^c   Yoshiike, Kunito ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

HIV 1; Inhibition; Integrase; Replication; Single chain antibodies

Indexed keywords

ENZYME ANTIBODY; INTEGRASE;

ANTIGEN ANTIBODY REACTION; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0033080821     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199902010-00001     Document Type: Article

References (49)

1. Brown PO, Bowerman B, Varmus HE, Bishop JM. Correct integration of retroviral DNA in vitro. Cell 1987:49:347-56.
2. Bowerman B, Brown PO, Bishop JM, Varmus HE. A nucleoprotein complex mediates the integration of retroviral DNA. Genes and Dev 1989;3:469-78.
3. Varmus H, Brown P. Retroviruses. In Howe M, Berg D, eds. Mobile DNA. Washington: ASM, 1989:53-108.
4. Brown PO. Integration of retroviral DNA. In Swanstrom R, Vogt PK, eds. Retroviruses: strategies of replication. New York: Springer-Verlag, 1990:19-48.
5. Farnet CM, Haseltine WA. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 1991;65:1910-15.
6. Gallay P, Swingler S, Song J, Bushman F, Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 1995;83:569-76.
7. Bird RE, Hardman KD, Jacobson JW, et al. Single-chain antigen-binding proteins [published erratum appears in Science 1989;28: 244:409]. Science 1988;242:423-6.
8. Chen SY, Bagley J, Marasco WA. Intracellular antibodies as a new class of therapeutic molecules for gene therapy. Hum Gene Ther 1994;5:595-601.
9. Winter G, Milstein C. Man-made antibodies. Nature 1991;349: 293-9.
10. Levy-Mintz P, Duan L, Zhang H, et al. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol 1996;70:8821-32.
11. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987;7:379-87.
12. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48.
13. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated b-galactosidase gene. J Virol 1992;66:2232-9.
14. ELI. Virology 1991;185:661-72.
15. Riggs P. Expression and purification of maltose-binding protein fusions. In Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols in molecular biology. New York: John Wiley & Sons, 1996:16.6.1-14.
16. Harlow E, Lane D. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988.
17. Goldfarb DS, Gariepy J, Schoolnik G, Kornberg RD. Synthetic peptides as nuclear localization signals. Nature 1986,322:641-644.
18. Izumi M, Miyazawa H, Kamakura T, Yamaguchi I, Endo T, Hanaoka F. Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. Exp Cell Res 1991;197:229-33.
19. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-9.
20. Van der Eb AJ, Mulder C, Graham FL, Houweling A. Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene 1977;2:115-32.
21. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of highliter helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993;90:8392-6.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
23. Ishiyama M, Tominaga H, Shiga M. et al. Novel cell proliferation and cytotoxicity assays using a tetrazolium salt that produces a water-soluble formazan dye. In Vitro Toxicol 1995;8:187-90.
24. Peden KWC, Martin MA. Virological and molecular genetic techniques for studies of established HIV isolates. In Karn J, ed. HIV: a practical approach. Oxford: IRL Press, 1995:21-45.
25. Miyake K, Tohyama T, Shimada T. Two-step gene transfer using an adenoviral vector carrying the CD4 gene and human immunodeficiency viral vectors. Hum Gene Ther 1996;7:2281-6.
26. Obaru K, Fujii S, Matsushita S, Shimada T, Takatsuki K. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1. Hum Gene Ther 1996;7:2203-8.
27. Walsh C, Cepko CL. Clonally related cortical cells show several migration patterns. Science 1988;241:1342-5.
28. Norton PA, Coffin JM. Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication. Mol Cell Biol 1985;5:281-90.
29. Okui N, Kobayashi N, Kitamura Y. Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase. J Virol 1998;72:6960-4.
30. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995;69:2729-36.
31. Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ. Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc Natl Acad Sci USA 1994;91:5075-9.
32. Duan L, Zhang H, Oakes JW, Bagasra O, Pomerantz RJ. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Hum Gene Ther 1994;5:1315-24.
33. Duan L, Zhu M, Bagasra O, Pomerantz RJ. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments. Hum Gene Ther 1995;6: 1561-73.
34. Wu Y, Duan L, Zhu M, et al. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition. J Virol 1996;70:3290-7.
35. Lodi PJ, Ernst JA, Kuszewski J, et al. Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 1995;34: 9826-33.
36. Eijkelenboom AP, Lutzke RA, Boelens R, Plasterk RH, Kaptein R, Hard K. The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat Struct Biol 1995;2:807-10.
37. Engelman A, Hickman AB, Craigie R. The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding. J Virol 1994;68:5911-17.
38. Lutzke RA, Vink C, Plasterk RH. Characterization of the minimal DNA-binding domain of the HIV integrase protein. Nucleic Acids Res 1994;22:4125-31.
39. Vink C, Oude Groeneger AM, Plasterk RH. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res 1993;21:1419-25.
40. Cannon PM, Byles ED, Kingsman SM, Kingsman AJ. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication. J Virol 1996;70:651-7.
41. Leavitt AD, Robles G, Alesandro N, Varmus HE. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 1996;70:721-8.
42. Adachi A, Gendelman HE, Koenig S, et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59:284-91.
43. Ratner L, Haseltine W, Patarca R, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985;313:277-84.
44. Nilsen BM, Haugan IR, Berg K, Olsen L, Brown PO, Heiland DE. Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro. J Virol 1996;70:1580-7.
45. Gargano N, Biocca S, Bradbury A, Cattaneo A. Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. J Virol 1996;70:7706-12.
46. Marasco WA, Haseltine WA, Chen SY. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc Natl Acad Sci USA 1993;90:7889-93.
47. Levin R, Mhashilkar AM, Dorfman T, et al. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol Med 1997;3:96-110.
48. Maciejewski JP, Weichold FF, Young NS, et al. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat Med 1995;1:667-673.
49. Shaheen F, Duan L, Zhu M, Bagasra O, Pomerantz RJ. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J Virol 1996;70:3392-3400.